Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s not clear whether the Department of Health will provide the data.

Data 52

Data Treatment Patients Chronic Pain 52

SpeedWeed

AUGUST 31, 2021

5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. 6, 2019, and Dec. Migraines accounted for 3,843 patients.

Programs 72

Programs Patients Dispensary Cultivation 72

Cannabis Law Report

MARCH 3, 2022

On February 28, 2022, the Oregon Psilocybin Services (OPS), a new section within the Oregon Health Authority (OHA), released results from a community interest survey concerning Oregon’s still-developing psilocybin program. The survey’s results show strong interest in the psilocybin program, particularly in accessing services.

Programs 52

Programs Access Data Legislation 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 250

Clinical Trials Chronic Pain Cannabinoids Patients 250

Veriheal

FEBRUARY 10, 2022

cloudPWR , a pioneer in cloud software for enterprise businesses and government agencies, is collaborating with fellow cloud-based solutions leader Accela to provide the South Dakota Department of Health (SDDOH) with an on-demand computer system-operated medical cannabis program registry. Med Card Registration via Cloud-based Registry.

Programs 52

Programs Chronic Pain Patients Conditions 52

Veriheal

NOVEMBER 21, 2023

Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Maya Woods-Arthur School: Harvard University Major/Program: Sociology Innovation: buddie Bluetooth bowl for tracking cannabis consumption.

Research and Development 108

Research and Development Consumption Education Data 108

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 243

Chronic Pain Therapy Patients Topical 243

SpeedWeed

SEPTEMBER 1, 2021

5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. 6, 2019, and Dec. Migraines accounted for 3,843 patients.

Programs 52

Programs Patients Dispensary Cultivation 52

Cannabis Law Report

FEBRUARY 23, 2022

Provides a conditional adult-use cultivator license to process and distribute cannabis flower products without holding an adult-use processor or distributor license; provides a conditional adult-use processor license to process and distribute cannabis products; provides for the repeal of certain provisions upon the expiration thereof.

Legislation 105

Legislation Conditions Cultivation Agriculture 105

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.

Chronic Pain 278

Chronic Pain Patients Therapy Data 278

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

The Cannigma

JUNE 30, 2021

But in addition to the 18 states with legal adult-use (as well as medical), there are another 18 states that have fully functioning medical marijuana programs. In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments.

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

The Joint Blog

JUNE 8, 2020

We continue to explore and report on new cannabis related university and certification programs that are popping up around the world to help meet the demand of employment for the sector. Interpret data to assess crop health and quality and adapt to growth conditions/pest management strategies. And much more!

Programs 32

Programs Research and Development Environment Packaging 32

Veriheal

SEPTEMBER 13, 2022

Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. As of July 2022, 38 states in America have legalized medical cannabis, and 19 states and the District of Columbia have established recreational cannabis programs.

Cultivation 109

Cultivation Data DEA Dispensary 109

Veriheal

NOVEMBER 18, 2022

A pair of boxing legends teamed up for an unexpected collaboration, Texas’ medical cannabis program saw big gains, and a hemp study revealed troubling signs for the industry. Texas’ Medical Cannabis Program Sees Growth Despite Limitations. Further, the state only has three dispensing organizations to serve its growing program.

Edibles 98

Edibles Hemp Epilepsy Programs 98

Canna Law Blog

SEPTEMBER 24, 2022

Given the expansive and stratified plans for New York’s adult-use cannabis industry (with the general ban on vertical integration, emphasis on social equity and advanced conditional licenses), the Director of Policy will have a quite a few responsibilities. First, the OCM clearly was looking for someone with a background in data analytics.

Policy 72

Policy Research and Development Data Legislation 72

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. This usage has not been extensively explored.”.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

NOVEMBER 22, 2021

Headset , a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting. Headset’s data shows that medical cannabis consumers tend to spend more money in order to purchase a larger supply at one time.

Recreational 98

Recreational Data Dispensary Medicine 98

Veriheal

JULY 25, 2023

Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. However, it is important to note that Quest Diagnostics amphetamines data does not separate prescribed medications like Adderall from illicit drug use. in 2021 and 3.1%

Safety 95

Safety Data Recreational Marijuana 95

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

AUGUST 16, 2022

The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window for the adult-use cannabis conditional cultivator licenses closed on June 30, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

SMPL

DECEMBER 1, 2020

Nicholas Scutari introduced legislation to implement the state’s adult-use cannabis program, just days after voters passed a legalization initiative on Election Day. Nearly seven in 10 Americans support legalizing the possession and use of cannabis by adults, according to nationwide polling data compiled and reported by Gallup.

Programs 40

Programs Legislation Decriminalization Policy 40

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

JUNE 19, 2022

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Canna Law Blog

DECEMBER 16, 2021

Expansive List of Qualifying Medical Conditions. The bill also provides for the creation a psilocybin services grant program fund for veterans and first responders to be jointly managed by the Commissioner of Health and the state comptroller. The bill allocates $2 million for the grant program. Broad Justification.

Legislation 96

Legislation Treatment Therapy Conditions 96

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. s (CSE: MXT) (OTC: MXTTF) SHAMAN and YMI programs apply machine learning to high-resolution health records to better diagnose mental health disorders. Building the Data Backend. population.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

SpeedWeed

MARCH 16, 2021

Many consumers were able to shop at different times because of new working conditions, or they deliberately avoided popular times. Analysis of hourly adult-use marijuana sales data showed that the percentage of evening sales – those after 5 p.m. The Oregon data includes medical marijuana sales information.

Data 52

Data Marijuana Retail Conditions 52

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used. And the process of adding additional conditions was often lengthy, difficult and mired in paternalism.

Policy 96

Policy Research and Development Conditions Consumption 96

Veriheal

JANUARY 1, 2024

Ohio’s Cannabis Landscape: Current Status and Future Outlook Ohio’s medical marijuana program, first launched in 2016 , brought legal access to patients managing certain debilitating conditions, but it took three years for dispensaries to open up due to regulatory challenges.

Recreational 113

Recreational Supply Chain Legislation Cannabis 113

Cannabis Law Report

DECEMBER 9, 2021

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52

CBD Data Compliance Compliance 52

Cannabis Law Report

AUGUST 9, 2021

The study will utilize Radicle Science’s data analytics platform and a virtual, direct-to-consumer model to deliver objective health outcome data across diverse populations and conditions. This randomized controlled trial will collect data on 13 U.S. Agri Pulse.

Hemp 105

Hemp CBD Legalization Edibles 105

Cannabis Law Report

AUGUST 27, 2021

New applicants may apply for either a conditional license or an annual license. Conditional license applications are prioritized over annual license applications to prioritize small business ownership. After the conditional license expires, the business must have its conversion application approved to begin operation.

Cultivation 105

Cultivation Conditions Business Cannabis 105